Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
Abstract Alterations in sodium flux (INa) play an important role in the pathogenesis of cardiac arrhythmias and may also contribute to the development of cardiomyopathies. We have recently demonstrated a critical role for the regulation of the voltage-gated sodium channel NaV1.5 in the heart by the...
Guardado en:
Autores principales: | Vassilios J. Bezzerides, Aifeng Zhang, Ling Xiao, Bridget Simonson, Santosh A. Khedkar, Shiro Baba, Filomena Ottaviano, Stacey Lynch, Katherine Hessler, Alan C. Rigby, David Milan, Saumya Das, Anthony Rosenzweig |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9af9999edb46428491a8bdbba7942bc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
por: Mengfei Cheng, et al.
Publicado: (2021) -
Serum- and glucocorticoid-regulated kinase 3 promotes proliferation and inhibits apoptosis of ER+ breast cancer cells
por: LIU Xu, et al.
Publicado: (2021) -
Monomorphic Ventricular Arrhythmias in Athletes
por: Jeffrey J Hsu, et al.
Publicado: (2019) -
Approach to inherited arrhythmias in pregnancy
por: Lisa Albertini, et al.
Publicado: (2021) -
Flight safety in patients with arrhythmia
por: Fahrettin Katkat
Publicado: (2021)